Comparing Quality of Recovery Between ESPB and IV Lidocaine After Major Breast Cancer Surgery
Not Applicable
Not yet recruiting
- Conditions
- Breast Neoplasms
- Registration Number
- NCT06490718
- Lead Sponsor
- Chinese University of Hong Kong
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
Inclusion Criteria:<br><br> - ASA I-III patients<br><br> - 18 to 75 years of age<br><br> - Patients scheduled for primary breast cancer surgery-mastectomy, modified radical<br> mastectomy and breast conservation surgery with sentinel lymph node biopsy +/-<br> axillary dissection will be included in this study.<br><br>Exclusion Criteria:<br><br> - Patient refusal,<br><br> - Local skin site infection,<br><br> - Coagulopathy,<br><br> - History of allergy to local anaesthetics, and<br><br> - Patients with hepatic, renal and cardiac dysfunction
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of Recovery;Area under the curve of postoperative pain
- Secondary Outcome Measures
Name Time Method Postoperative opioid consumption